The company's quarterly filing showsNet Incomeof USD 6.3 million for the quarter, against USD 8.8 million a year earlier. Net income attributable to Cohen & Company Inc. was USD 6.7 million, against USD 4.6 million.
Total revenues were USD 0.2 million for the quarter, against USD 0.1 million in the prior-year period. For the nine months, revenues were USD 0.3 million, against USD 0.4 million. Interest income was USD 0.4 million for the quarter, against USD 0.7 million, and …
Chief Executive Officer James Dentzer said the company continues to make progress in its TakeAim Lymphoma study in primary CNS lymphoma, or PCNSL, a registrational study of emavusertib in combination with ibrutinib in relapsed or refractory patients.
Third-quarter revenue consisted of USD 17.2 million in DefenCath net sales and USD 37.3 million from the rest of the portfolio. The rest of the portfolio comprised USD 31.4 million of product sales and approximately USD 5.9 million of contract revenue and grant income …
The filing shows net income of USD 1,317 thousand, against USD 1,157 thousand in the same quarter a year earlier, with earnings per share of USD 0.12, against USD 0.11.
Chief Executive Officer Chuck Robbins said the company is increasing its fiscal 2027 guidance and sees growingDemandas customers invest in infrastructure for the AI era. On aGAAPbasis, the press release listsNet Incomeof USD 4.6 billion, against USD 2.9 billion, andDiluted Earnings per Shareof USD …
The company said growth was led by a 16% increase in distributor and strategic partner sales. Gross margin was 75%, against 73% in the second quarter of 2026 and 70% a year ago. Total operating expenses were USD 8.5 million, against USD 9.5 million, …
Management said the quarter reflected a competitive pricing environment in the U.S. for small bowel capsule endoscopy, even as the company continued to expand its customer base. It said it plans to submit its second-generation colon platform to the FDA before year-end 2026.
Platform revenue was USD 3.8 million, against USD 3.5 million. The company attributed the USD 0.3 million increase primarily to a USD 0.3 million rise in fund management fees and a USD 0.2 million rise in development and construction fees, partly offset by a …
The company is an autonomous vehicle technology company focused on industrial uses. Its DriveMod software is a modular autonomous driving system for industrial vehicles, and the Enterprise Autonomy Suite is designed to integrate with sensors and components from hardware providers.